Evaluate the Efficacy and Safety of Proso Millet and Wheat Extract(Keranat™) on Hair Health

Nutracore

Status

Completed

Conditions

Hair Damage

Treatments

Dietary Supplement: placebo

Dietary Supplement: Keranat™

Study type

Interventional

Funder types

Industry

Other

Identifiers

NCT06237959

NC07-NOVA-2022

Details and patient eligibility

About

The purpose of this randomized, double-blind, placebo-controlled study will be to evaluate whether the daily intake of Keranat™ for 24 weeks can promote the gloss and elasticity of hairs, improve their density and strength, and reduce hair loss.

Enrollment

100 patients

Sex

All

Ages

19 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age 19 and 60
Hair gloss score of 3 or less and a hair damage score of less than 18 according to the visual evaluation classification method.
Willing to maintain the same hairstyle, hair color, hair length, and hair regimen throughout the study period.
Subject must be able to comprehend and voluntarily sign study procedures and consent forms.

Exclusion criteria

Those diagnosed with and receiving treatment for the alopecia within 3 months before screening(androgenetic alopecia, alopecia areata, Telogen effluvium, etc.)
Use of that may affect hair or hair loss symptoms treatment medicine, dietary supplements, or treatments containing herbal medicine ingredients within 3 months before screening.
Any active scalp or skin disease that may interfere with the study treatment and evaluations.
Pregnancy or breastfeeding or planning pregnancy
Case of abnormal values at creatinine (excess at the upper limit of the reference range)
Case of abnormal values at ALT or AST (2 times excess at the upper limit of the reference range)